Psychedelics promise a "paradigm shift" in treating mental illness.
—Newsweek, September 2015
Conference: Interdisciplinary Research Track
Elena Argento, Ph.D. Candidate
Psychedelic Use Predicts Reduced Suicidality: Findings From a Longitudinal Study of Women Sex Workers in Vancouver, Canada
Erika Dyck, Ph.D.
Who is Keeping Tabs? LSD Lessons from the Past
James Fadiman, Ph.D., and Sophia Korb, Ph.D.
Preliminary Results from Psychedelic Microdosing Study
Kevin Franciotti, M.A.
The Use of Psychedelics in the Treatment of Psychotic Disorders
John Hartberg, B.Sc., M.D. Candidate
Ketamine’s Therapeutic Potential: Practical Considerations for Clinical Use
Katherine Hendy, Ph.D.
The Placebo Paradox
Ethan Nadelmann, Ph.D.
Drug Policy and Psychedelics
Elizabeth M. Nielson, Ph.D.
Psychedelic Therapists: Perspectives on the Therapeutic Process in Psilocybin Assisted Therapy
Neiloufar Family, Ph.D
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Low Dose LSD: A Phase 1 Study
Milan Scheidegger, M.D., Ph.D., M.A. HPK
Psilocybin Enhances Mindfulness-Related Capabilities in a Meditation Retreat Setting: A Double-Blind Placebo-Controlled fMRI Study
Emmanuelle A. D. Schindler, M.D., Ph.D.
Indoleamine Hallucinogens in the Treatment of Cluster Headache
Thomas Cody Swift, M.A., and Alexander Belser, Ph.D. Candidate
Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological Distress
Tomas Palenicek, M.D., Ph.D.
The Effects of Psilocybin on Perception and the Dynamics of Induced EEG/fMRI Correlates of Psychedelic Experience